Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

Severe Strongyloides stercoralis, such as hyperinfection syndrome, carries a high mortality risk. Even with appropriate treatment, patients may experience infectious complications and failure of therapy. Currently, there are no Food and Drug Administration–approved parenteral therapies available for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeitler, Kristen, Jariwala, Ripal, Restrepo-Jaramillo, Ricardo, Kapadia, Shyam, Casanas, Beata, Alrabaa, Sally, Sriaroon, Chakrapol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990086/
https://www.ncbi.nlm.nih.gov/pubmed/29866667
http://dx.doi.org/10.1136/bcr-2017-223138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990086/
https://www.ncbi.nlm.nih.gov/pubmed/29866667
http://dx.doi.org/10.1136/bcr-2017-223138

Ejemplares similares